Literature DB >> 15765373

Clinical applications of 99mTc-sestamibi scintimammography.

Raymond Taillefer1.   

Abstract

Mammography is the imaging modality of choice in detection of early, nonpalpable breast cancer. However, scintimammography may prove to be a very useful adjunct to a nondiagnostic or difficult mammography. Future prospective studies will have to be designed so that the specific clinical applications of scintimammography will be well defined. To be clinically relevant, each niche where scintimammography is potentially indicated should be clearly evaluated and incorporated into an algorithm of investigation of breast cancer, taking into consideration the relative advantages and limitations of scintimammography. Special care to obtain high-quality scintimammographic studies is mandatory. Because poor quality studies may be the major drawback, the nuclear medicine community should remind the lesson learned from radiologic mammography. Furthermore, it is also hoped that significant improvement in the scintigraphic equipment and data acquisition will be seen in a very near future to have more widespread clinical diagnostic applications of scintimammography.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15765373     DOI: 10.1053/j.semnuclmed.2004.11.002

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  8 in total

1.  [Functional and molecular imaging of breast tumors].

Authors:  K Pinker; P Brader; G Karanikas; K El-Rabadi; W Bogner; S Gruber; M Reisegger; S Trattnig; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

2.  Molecular Imaging in Breast Cancer - Potential Future Aspects.

Authors:  Katja Pinker; Wolfgang Bogner; Stephan Gruber; Peter Brader; Siegfried Trattnig; Georgios Karanikas; Thomas H Helbich
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

3.  Single-photon-emission computed tomography (SPECT) with 99 technetium sestamibi in the diagnosis of small breast cancer and axillary node involvement.

Authors:  Hans Jacobsson
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

4.  [Molecular breast imaging. An update].

Authors:  K Pinker; T H Helbich; H Magometschnigg; B Fueger; P Baltzer
Journal:  Radiologe       Date:  2014-03       Impact factor: 0.635

5.  Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade.

Authors:  R V Tadwalkar; J A Rapelyea; J Torrente; L R Rechtman; C B Teal; A P McSwain; C Donnelly; A B Kidwell; C M Coffey; R F Brem
Journal:  Br J Radiol       Date:  2011-06-28       Impact factor: 3.039

6.  Planar Tc99m--sestamibi scintimammography should be considered cautiously in the axillary evaluation of breast cancer protocols: results of an international multicenter trial.

Authors:  Teresa Massardo; Omar Alonso; Augusto Llamas-Ollier; Levin Kabasakal; Uma Ravishankar; Rossana Morales; Lucía Delgado; Ajit K Padhy
Journal:  BMC Nucl Med       Date:  2005-07-27

7.  99mTc-thymine scintigraphy may be a promising method in the diagnosis of breast cancer.

Authors:  Monica Pires Ribeiro; Sergio Augusto Lopes de Souza; Flavia Paiva Proença Lobo Lopes; Paulo Henrique Rosado-de-Castro; Lea Mirian Barbosa da Fonseca; Bianca Gutfilen
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

Review 8.  The role of general nuclear medicine in breast cancer.

Authors:  Lacey R Greene; Deborah Wilkinson
Journal:  J Med Radiat Sci       Date:  2015-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.